Cargando…
The clinical role of microRNA-21 as a promising biomarker in the diagnosis and prognosis of colorectal cancer: a systematic review and meta-analysis
This systematic analysis aimed to investigate the value of microRNA-21 (miR-21) in colorectal cancer for multiple purposes, including diagnosis and prognosis, as well as its predictive power in combination biomarkers. Fifty-seven eligible studies were included in our meta-analysis, including 25 stud...
Autores principales: | Peng, Qiliang, Zhang, Xueli, Min, Ming, Zou, Li, Shen, Peipei, Zhu, Yaqun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5546529/ https://www.ncbi.nlm.nih.gov/pubmed/28415652 http://dx.doi.org/10.18632/oncotarget.16488 |
Ejemplares similares
-
Identification of microRNA‐181 as a promising biomarker for predicting the poor survival in colorectal cancer
por: Peng, Qiliang, et al.
Publicado: (2019) -
Identification of biomarker microRNAs for predicting the response of colorectal cancer to neoadjuvant chemoradiotherapy based on microRNA regulatory network
por: Zhu, Yaqun, et al.
Publicado: (2016) -
Identification of microRNA-92a and the related combination biomarkers as promising substrates in predicting risk, recurrence and poor survival of colorectal cancer
por: Peng, Qiliang, et al.
Publicado: (2019) -
Biomarker exploration of microRNA-203 as a promising substrate for predicting poor survival outcome in colorectal cancer
por: Peng, Qiliang, et al.
Publicado: (2020) -
MicroRNA‐21 was a promising biomarker for lung carcinoma diagnosis: An update meta‐analysis
por: Wang, Haiyan, et al.
Publicado: (2021)